Clinical Trials on Rotavirus Immunisation

Total 369 results

The Ottawa Hospital

Completed

Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform

Mobile Apps | Immunization | Adverse Event Following Immunisation

Canada
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Polio Immunisation | Haemophilus Influenzae Type B Immunisation | Rotavirus Immunisation

Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps Immunisation

United States, Canada, Honduras, Puerto Rico
University of Alabama at Birmingham

Completed

Low Cost Interventions to Improve Adherence to Childhood Immunization Schedule

Childhood Immunization Completion | Childhood Immunization Dropout | Immunization Card | Center Based Education

Pakistan
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus | Rotavirus Vaccines

United States, Finland, Germany, Taiwan, Spain, Costa Rica, Korea, Republic of, Japan
GlaxoSmithKline

Completed

Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants

Infections, Rotavirus | Rotavirus Vaccines

Japan
GlaxoSmithKline

Completed

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

Rotavirus Infection | Rotavirus Vaccines

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
University of Padova; Centers for Disease Control and Prevention; Aga Khan University and other collaborators

Completed

The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan

Rotavirus

Pakistan
Merck Sharp & Dohme LLC

Terminated

A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)

Rotavirus
Sichuan Center for Disease Control and Prevention
China National Biotec Group Company Limited

Unknown

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

Rotavirus
Merck Sharp & Dohme LLC

Completed

V260 Registration Study (V260-013)(COMPLETED)

Rotavirus
GlaxoSmithKline

Completed

Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants

Rotavirus

India
GlaxoSmithKline

Completed

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

Infections, Rotavirus | Rotavirus Vaccines

Philippines
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Meningococcal Immunisation

United States, Puerto Rico
Sanofi

Completed

Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.

Pneumoccocal Immunisation

United States
GlaxoSmithKline

Completed

A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.

Infections, Rotavirus | Rotavirus Vaccines

Philippines
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants

Infections, Rotavirus | Rotavirus Vaccines

Korea, Republic of
GlaxoSmithKline

Completed

A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan

Rotavirus Gastroenteritis | Nosocomial Rotavirus Gastroenteritis
Taipei Medical University Shuang Ho Hospital

Unknown

Using "Decision Aids" to Help the Infant Family to Decide the Use of Oral Rotavirus Vaccine

Rotavirus Vaccines

Taiwan
National Institute of Pediatrics, Mexico
Merck Sharp & Dohme LLC; Centro Nacional para la Salud de la Infancia y la...

Completed

Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs

Rotavirus Vaccine

Mexico
PATH
Bill and Melinda Gates Foundation; Children's Hospital Medical Center, Cincinnati and other collaborators

Completed

Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

Rotavirus Vaccine

South Africa
GlaxoSmithKline

Completed

Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis

Infections, Rotavirus | Rotavirus Vaccines

Japan
GlaxoSmithKline

Completed

Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children

Infections, Rotavirus | Rotavirus Vaccines

Belgium
GlaxoSmithKline

Completed

Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden

Infections, Rotavirus | Rotavirus Gastroenteritis
Sanofi Pasteur, a Sanofi Company

Recruiting

Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers

Healthy Volunteers | Meningococcal Immunisation

Czechia, Denmark, Finland, Germany, Poland, Romania
Romark Laboratories L.C.

Completed

Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children

Rotavirus Infection | Viral Gastroenteritis Due to Rotavirus

Egypt
Seattle Children's Hospital
National Center for Research Resources (NCRR); Thrasher Research Fund

Completed

Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure

Intestinal Failure | Rotavirus Vaccines

United States
Duke University
University of South Carolina; Fogarty International Center of the National... and other collaborators

Completed

mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (MINT)

Immunization

Tanzania
CAMC Health System

Completed

Effect of Infant Immunization on Procalcitonin Levels - A Pilot Study

Immunization

United States
Auburn University
Agency for Healthcare Research and Quality (AHRQ)

Completed

Assessing Barriers and Increasing Use of Immunization Registries in Pharmacies

Immunization

United States
GlaxoSmithKline

Completed

Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus

United States, Taiwan, Canada, Hong Kong, Turkey
GlaxoSmithKline

Completed

Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

Infections, Rotavirus
GlaxoSmithKline

Completed

Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants

Infections, Rotavirus

China
GlaxoSmithKline

Completed

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

Infections, Rotavirus

Singapore
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

Infections, Rotavirus

United States
GlaxoSmithKline

Completed

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Infections, Rotavirus

Argentina, Brazil, Dominican Republic, Panama, Colombia, Honduras
GlaxoSmithKline

Completed

Drug Use Investigation for ROTARIX®

Infections, Rotavirus
GlaxoSmithKline

Completed

Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination

Infections, Rotavirus
Sanofi Pasteur, a Sanofi Company

Recruiting

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers (PEARL)

RSV Immunisation

United States, Argentina, Honduras
PATH

Completed

A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine

Rotavirus Infection

United States
GlaxoSmithKline

Completed

Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States

Infections, Rotavirus

United States
GlaxoSmithKline

Completed

Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India

Infections, Rotavirus

India
GlaxoSmithKline

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Infections, Rotavirus

Finland, Germany, Spain, Italy, France, Czech Republic
Merck Sharp & Dohme LLC

Completed

V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)

Rotavirus Disease
GlaxoSmithKline
Analysis Group, Inc.

Completed

Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination

Infections, Rotavirus
GlaxoSmithKline

Completed

A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.

Infections, Rotavirus

Dominican Republic, Honduras, Panama, Mexico, Brazil, Argentina, Colombia, Chile, Finland, Nicaragua, Peru, Venezuela
GlaxoSmithKline

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age

Infections, Rotavirus

Taiwan
GlaxoSmithKline

Completed

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011

Infections, Rotavirus
GlaxoSmithKline

Completed

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007

Infections, Rotavirus

3

Subscribe